| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/09/2009 | CN101596166A Aspirin enteric-coated pellet |
| 12/09/2009 | CN101596163A Paracetamol, caffeine and aspirin pellet preparation and preparation method thereof |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100566725C Specific medicine for treating appendicitis |
| 12/09/2009 | CN100566710C New use of 6,7-dehydroroyleanone in pharmaceutical |
| 12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |
| 12/08/2009 | US7629471 Transcriptional factor, process for producing the same and use thereof |
| 12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
| 12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 12/08/2009 | US7629368 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
| 12/08/2009 | US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |
| 12/08/2009 | US7629313 Immunomodulatory polymeric antigens for treating inflammatory pathologies |
| 12/08/2009 | US7629163 Methods for producing modified glycoproteins |
| 12/08/2009 | US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo |
| 12/08/2009 | US7628991 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
| 12/08/2009 | CA2452827C Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 12/08/2009 | CA2440744C Il-12 expression controlling agent |
| 12/08/2009 | CA2424396C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2419301C Quinazoline derivatives |
| 12/08/2009 | CA2415486C Pyramidine derivatives |
| 12/08/2009 | CA2404725C Extrusion die |
| 12/08/2009 | CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/08/2009 | CA2375986C Substituted pyrazole compounds |
| 12/08/2009 | CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/08/2009 | CA2358289C Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 12/08/2009 | CA2333475C Derivatives of pyrazolines, their preparation and their application as medicaments |
| 12/08/2009 | CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide |
| 12/08/2009 | CA2315113C Pyridones as src family sh2 domain inhibitors |
| 12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
| 12/03/2009 | WO2009146288A1 Processes and compounds for the preparation of normorphinans |
| 12/03/2009 | WO2009146218A2 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/03/2009 | WO2009146030A1 Methods and systems for reducing inflammation by neuromodulation of t-cell activity |
| 12/03/2009 | WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 12/03/2009 | WO2009144961A1 Substituted carbinol compound having cyclic linker |
| 12/03/2009 | WO2009144201A1 Imidazopyridine derivatives as gpr4 receptor modulators |
| 12/03/2009 | WO2009144038A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| 12/03/2009 | WO2009143864A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| 12/03/2009 | WO2009143558A1 Injectable formulations |
| 12/03/2009 | WO2009117987A3 Use of boswellia acids and synthetic boswellia acid derivatives for inhibiting microsomal prostanglandin e2 synthase and cathepsin g |
| 12/03/2009 | WO2009114088A3 Fullerene therapies for inflammation |
| 12/03/2009 | WO2009040512A3 Modulation of rsk |
| 12/03/2009 | US20090300776 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation |
| 12/03/2009 | US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 12/03/2009 | US20090298929 Novel natural cyclodextrin complexes |
| 12/03/2009 | US20090298897 Treatment of Inflammatory Disorders With Triazole Compounds |
| 12/03/2009 | US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| 12/03/2009 | US20090298885 Methylene urea derivatives |
| 12/03/2009 | US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 12/03/2009 | US20090298867 Tricyclic delta-opioid modulators |
| 12/03/2009 | US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells |
| 12/03/2009 | US20090298829 Melanocortin receptor agonists |
| 12/03/2009 | US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/03/2009 | US20090298807 Compounds |
| 12/03/2009 | US20090298803 Pharmaceutical composition comprising fluocinonide |
| 12/03/2009 | US20090298794 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 12/03/2009 | US20090298788 5-[6-Amino-2-(2-hydroxy-adamantan-2-ylethynyl)-purin-9-yl]-3,4-dihydroxy-tetrahydro-furan-2-carboxylic acid cyclopropylamide for the treatment of inflammatory activity in mammalian tissue; A2A adenosine receptor agonist; autoimmune stimulation, allergic diseases, skin diseases, infectious diseases |
| 12/03/2009 | US20090298747 Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions |
| 12/03/2009 | US20090298744 Heterocyclic compounds as adenosine receptor antagonist |
| 12/03/2009 | US20090297624 Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans |
| 12/03/2009 | US20090297619 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 12/03/2009 | US20090297532 Antibody Neutralizers of Human Granulocyte Macrophage Colony Stimulating Factor |
| 12/03/2009 | US20090297510 Inhibition of calpain reduces allergic inflammation |
| 12/03/2009 | US20090297499 Use of charcoal for treating inflammatory conditions |
| 12/03/2009 | US20090297444 Peptide analogs of alpha-melanocyte stimulating hormone |
| 12/03/2009 | CA2725547A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| 12/03/2009 | CA2725111A1 Substituted carbinol compound having a cyclic linker |
| 12/03/2009 | CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 12/03/2009 | CA2721665A1 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/02/2009 | EP2128265A1 Method for glycosylation of flavonoid |
| 12/02/2009 | EP2128248A1 Oligonucleotide compositions with enhanced efficiency |
| 12/02/2009 | EP2128157A1 Heterocyclidene-n-(aryl)acetamide derivative |
| 12/02/2009 | EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 12/02/2009 | EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 12/02/2009 | EP2128123A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| 12/02/2009 | EP2127681A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 12/02/2009 | EP2127673A1 Pharmaceutical agent for prevention and treatment of skin disease induced by accelerated keratinization |
| 12/02/2009 | EP2127668A1 Enzyme composition and use thereof |
| 12/02/2009 | EP2127662A1 Rankl production inhibitor |
| 12/02/2009 | EP2126092A2 Fusion proteins binding to growth factors |
| 12/02/2009 | EP2125831A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 12/02/2009 | EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 12/02/2009 | EP2125747A1 1,5-diaryl-pyrazoles as cannabinoid receptor neutral antagonists useful as therapeutic agents |
| 12/02/2009 | EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 12/02/2009 | EP2125059A1 Treatment of inflammatory and/or bacterial conditions with particles of microstructure |
| 12/02/2009 | EP2124983A2 A herbal preparation effective in the prevention and management of rheumatoid arthritis and associated complaints |
| 12/02/2009 | EP2124977A1 Method for treating or preventing systemic inflammation |
| 12/02/2009 | EP2124966A2 Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
| 12/02/2009 | EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 12/02/2009 | EP2124934A2 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline |